Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S322000, C514S323000, C546S198000, C546S199000, C546S200000, C546S201000
Reexamination Certificate
active
08008326
ABSTRACT:
The present invention relates to new 4-benzylidene-piperidin derivatives of formula (I), useful as NMDA, in a particular NR2B subunit containing receptor antagonists and analgesica.
REFERENCES:
patent: 6359138 (2002-03-01), Alanine et al.
patent: 2004/0157886 (2004-08-01), Domany et al.
Kornberg et al. “Subtype selectvie NMDA . . . ” Bioorg. Med. Chem. Lett. v. 14, p. 1213-1216 (2004).
Borza Istvan
Farkas Sandor
Galgoczy Kornel
Gyertyan Istvan
Horvath Csilla
Chang Celia
Fish & Richardson P.C.
Richter Gedeon Vegyeszeti Gyar Rt.
LandOfFree
4-benzyledene-piperidin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-benzyledene-piperidin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-benzyledene-piperidin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674031